JP2022516054A5 - - Google Patents
Info
- Publication number
- JP2022516054A5 JP2022516054A5 JP2021536744A JP2021536744A JP2022516054A5 JP 2022516054 A5 JP2022516054 A5 JP 2022516054A5 JP 2021536744 A JP2021536744 A JP 2021536744A JP 2021536744 A JP2021536744 A JP 2021536744A JP 2022516054 A5 JP2022516054 A5 JP 2022516054A5
- Authority
- JP
- Japan
- Prior art keywords
- dna aptamer
- cancer
- sequence
- treatment composition
- deformation
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180167948 | 2018-12-21 | ||
| KR10-2018-0167948 | 2018-12-21 | ||
| PCT/KR2019/009956 WO2020130269A1 (ko) | 2018-12-21 | 2019-08-08 | 신규한 dna 앱타머 및 이의 용도 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022516054A JP2022516054A (ja) | 2022-02-24 |
| JPWO2020130269A5 JPWO2020130269A5 (https=) | 2022-07-14 |
| JP2022516054A5 true JP2022516054A5 (https=) | 2022-07-14 |
| JP7391971B2 JP7391971B2 (ja) | 2023-12-05 |
Family
ID=71100532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536744A Active JP7391971B2 (ja) | 2018-12-21 | 2019-08-08 | 新規のｄｎａアプタマー及びこれの用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12398395B2 (https=) |
| EP (1) | EP3901287A4 (https=) |
| JP (1) | JP7391971B2 (https=) |
| KR (1) | KR102324242B1 (https=) |
| CN (1) | CN113646442B (https=) |
| WO (2) | WO2020130225A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020130225A1 (ko) * | 2018-12-21 | 2020-06-25 | 국립암센터 | 췌장암 특이적으로 결합하는 dna 앱타머 및 이의 용도 |
| KR102506295B1 (ko) | 2020-08-28 | 2023-03-08 | 국립암센터 | 디그옥시제닌에 대한 인간화 항체 및 이의 용도 |
| KR102506288B1 (ko) * | 2020-09-07 | 2023-03-06 | 국립암센터 | 디그옥시제닌에 대한 항체를 포함하는 복합체, 및 이들의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US8563711B2 (en) * | 2009-06-01 | 2013-10-22 | Sungkyunkwan University Foundation For Corporate Collaboration | Nucleic acid aptamer capable of binding specifically to pancreatic cancer cells or tissues and use thereof |
| KR101250557B1 (ko) * | 2011-05-18 | 2013-04-03 | 국립암센터 | Ｐａｕｆ 특이적 앱타머 및 이를 포함하는 췌장암 치료용 조성물 |
| KR101699105B1 (ko) * | 2012-04-02 | 2017-01-23 | 성균관대학교산학협력단 | Ａｌｐｐｌ２ 단백질을 이용한 췌장암 진단 방법 |
| KR101568400B1 (ko) * | 2012-08-09 | 2015-11-12 | 연세대학교 산학협력단 | 암 줄기세포에 특이적으로 결합하는 핵산 앱타머 및 이의 용도 |
| KR101458947B1 (ko) * | 2013-03-05 | 2014-11-12 | 국립암센터 | 인터루킨-８ 앱타머 및 이의 용도 |
| AU2016346269A1 (en) * | 2015-10-30 | 2018-05-24 | Tagcyx Biotechnologies | DNA aptamer binding to cancer cell |
| WO2020130225A1 (ko) * | 2018-12-21 | 2020-06-25 | 국립암센터 | 췌장암 특이적으로 결합하는 dna 앱타머 및 이의 용도 |
| KR102506295B1 (ko) * | 2020-08-28 | 2023-03-08 | 국립암센터 | 디그옥시제닌에 대한 인간화 항체 및 이의 용도 |
| KR102506288B1 (ko) * | 2020-09-07 | 2023-03-06 | 국립암센터 | 디그옥시제닌에 대한 항체를 포함하는 복합체, 및 이들의 용도 |
-
2019
- 2019-02-01 WO PCT/KR2019/001416 patent/WO2020130225A1/ko not_active Ceased
- 2019-08-08 CN CN201980092801.6A patent/CN113646442B/zh active Active
- 2019-08-08 EP EP19900348.4A patent/EP3901287A4/en active Pending
- 2019-08-08 JP JP2021536744A patent/JP7391971B2/ja active Active
- 2019-08-08 WO PCT/KR2019/009956 patent/WO2020130269A1/ko not_active Ceased
- 2019-08-08 US US17/416,858 patent/US12398395B2/en active Active
- 2019-08-08 KR KR1020190096665A patent/KR102324242B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013256341B2 (en) | Novel tetraGalNAc and peptide containing conjugates and methods for delivery of oligonucleotides | |
| ES2899043T3 (es) | Novedosos conjugados de oligonucleótidos y su uso | |
| Gooding et al. | Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis | |
| KR20200097751A (ko) | 근위축증 및 근긴장성 이영양증을 치료하는 조성물 및 방법 | |
| TW202540423A (zh) | 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法 | |
| JP2022516054A5 (https=) | ||
| CN119816292A (zh) | 基于甾醇的可电离脂质以及包含其的脂质纳米颗粒 | |
| WO2009008727A3 (en) | Molecules for targeting compounds to various selected organs or tissues | |
| JP2021505661A5 (https=) | ||
| Kim et al. | Biomimetic DNA nanoballs for oligonucleotide delivery | |
| CN107980001A (zh) | 包括硫代磷酸化寡脱氧核苷酸的化合物和组合物及其使用方法 | |
| CN114158253A (zh) | 强效细胞毒性化合物的pHLIP®靶向递送 | |
| Sk et al. | Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: a comparative study | |
| US20160168573A1 (en) | LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME | |
| JP2016501523A5 (https=) | ||
| JP2016523557A5 (https=) | ||
| US20200108089A1 (en) | Gemcitabine Derivatives for Cancer Therapy | |
| JP2016523557A (ja) | 肝臓癌関連遺伝子特異的ｓｉＲＮＡ、そのようなｓｉＲＮＡを含む二重らせんオリゴＲＮＡ構造体及びこれを含む癌予防または治療用組成物 | |
| US12054714B2 (en) | Peptide docking vehicle for targeted nucleic acid delivery | |
| Weiss et al. | Uronic acids functionalized polyethyleneimine (PEI)–polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers | |
| JP2018536655A5 (https=) | ||
| JP2018527360A5 (https=) | ||
| US20190209695A1 (en) | Pharmaceutical Compositions for High-Capacity Targeted Delivery | |
| CN105779458B (zh) | 对非小细胞肺癌具有抑制作用的核糖核酸适配体及包含其的药物组合物 | |
| US9492470B2 (en) | Use of HMGA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells |